Connecting clients, partners and patients to develop new treatments for diabetes and related metabolic diseases.
Clinical Development and Regulatory Strategy + State-of-the-Art Clinical Facility + Full Scope CRO Services + Global Scientific Network
ProSciento’s President and Chief Development Officer to Present at NASH Summit Read More »
mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population Read More »
View Our Presentation
Allergan, Novartis ink NASH partnership Read More »
NEJM study reports long-term mortality and CV disease outcomes for type 1 and type 2 diabetes Read More »
Nature study highlights novel diabetes drug with potential to restore insulin sensitivity in mice Read More »